Evidence map›Paper›PMID 33401388›Full record

ArticleMarine drugs2021

AhaP, A Quorum Quenching Acylase from

José Carlos Reina, Manuel Romero, Rafael Salto, Miguel Cámara, Inmaculada Llamas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Frontiers in microbiology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Novel Bifunctional Acylase fromAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

José Carlos ReinaDepartment of Microbiology, Faculty of Pharmacy, Campus Universitario Cartuja s/n, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-6418-9805
Manuel RomeroNational Biofilms Innovation Centre, Biodiscovery Institute and School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0001-6902-6776
Rafael SaltoDepartment of Biochemistry, Faculty of Pharmacy, Campus Universitario Cartuja s/n, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-7044-3611
Miguel CámaraNational Biofilms Innovation Centre, Biodiscovery Institute and School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0003-4585-7385
Inmaculada LlamasDepartment of Microbiology, Faculty of Pharmacy, Campus Universitario Cartuja s/n, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-6333-5033
Universidad de Granada · ESUniversity of Nottingham · GB

Funding

nnovation and Knowledge Centre funded by the Biotechnology and Biological Sciences Research Council, InnovateUK and Hartree Centre BB/R012415/1Spanish Ministry of Education, Culture and Sport FPU15/01717Spanish Ministry of the Economy and Competitiveness AGL2015-68806-RSpanish Ministry of the Economy and Competitiveness and State Research Agency (AEI) PID2019-106704RB-100/SRA
6 · The paper itself

Abstract

Although

Indexed as

4-ButyrolactoneAcyl-ButyrolactonesAmidohydrolasesAnimalsArtemiaGenome, BacterialMolecular StructurePseudomonas aeruginosaPsychrobacterQuorum SensingRNA, Ribosomal, 16SVibrioVirulence4-ButyrolactoneAcyl-ButyrolactonesamidaseAmidohydrolaseshomoserine lactoneRNA, Ribosomal, 16Sacylasemarine habitatPsychrobacterquorum quenching

Identifiers

PMID33401388
PMCPMC7823738
OpenAlexW3113952128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.